retatrutide creator With approaching ~30% weight loss at 2 years—but with what appears to be a meaningfully higher adverse event burden than earlier-generation incretin therapies—expert clinical guidance… How are bodybuilders and #fitness

Approximate dose correspondence (not equivalence) Notice how each semaglutide dose maps to a range of tirzepatide doses, not a single number

Tirzepatide is a dual-agonist targeting GLP-1 and GIP receptors, while retatrutide is a triple-agonist that also activates the glucagon receptor

It is mostly used in lightening dark spots and other types of pigmentation on the face and neck

Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration

It is suggested that bariatric surgery interferes with the usual PNS-mediated reactions to hypoglycaemia [32]

The crucial caveat here is to avoid freeze-thaw cycles